Drug intelligence / Profile preview

Nephrovit

Development stage: Unknown
Lead developer: Osve Pharmaceutical
Modality: Small Molecules
Administration: Oral

Overview

Nephrovit is a specialized renal multivitamin supplement formulated for patients with chronic kidney disease (CKD), particularly those undergoing hemodialysis. It contains a combination of water-soluble vitamins, including the B-complex (B1, B2, B3, B5, B6, B7, B9, and B12) and Vitamin C (ascorbic acid). These nutrients are essential for metabolic functions and are frequently depleted during dialysis or restricted by the renal diet. In clinical settings, such as the Phase III trial (NCT03408639) comparing CinnaPoietin and Eprex, Nephrovit is administered as supportive therapy to prevent vitamin deficiencies and support the management of anemia in patients with end-stage renal disease (ESRD).

Brand names: Nephrovit
Other names: renal multivitamin

Beyond the preview

Go deeper on Nephrovit.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Nephrovit.

Explore the full profile